HBT
PBE icon

Hills Bank & Trust’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Hills Bank & Trust’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$361K Hold
4,559
– – 0.02% 235
2025
Q4 		$375K Sell
4,559
-88
-2% -$6.81K 0.02% 224
2025
Q3 		$325K Sell
4,647
-240
-5% -$16.2K 0.02% 231
2025
Q2 		$313K Sell
4,887
-330
-6% -$20.4K 0.02% 225
2025
Q1 		$331K Sell
5,217
-960
-16% -$64.6K 0.02% 213
2024
Q4 		$411K Sell
6,177
-34
-0.5% -$2.34K 0.03% 201
2024
Q3 		$434K Sell
6,211
-498
-7% -$34.5K 0.03% 195
2024
Q2 		$435K Sell
6,709
-128
-2% -$8.11K 0.04% 186
2024
Q1 		$442K Sell
6,837
-249
-4% -$16.2K 0.04% 182
2023
Q4 		$467K Sell
7,086
-128
-2% -$7.44K 0.05% 171
2023
Q3 		$411K Sell
7,214
-158
-2% -$9.63K 0.05% 167
2023
Q2 		$452K Sell
7,372
-150
-2% -$9.36K 0.06% 150
2023
Q1 		$472K Sell
7,522
-513
-6% -$33.1K 0.07% 144
2022
Q4 		$510K Sell
8,035
-677
-8% -$43K 0.08% 138
2022
Q3 		$514K Sell
8,712
-178
-2% -$11K 0.08% 128
2022
Q2 		$513K Sell
8,890
-433
-5% -$24.9K 0.08% 133
2022
Q1 		$578K Sell
9,323
-1,037
-10% -$63.3K 0.08% 128
2021
Q4 		$738K Hold
10,360
– – 0.1% 117
2021
Q3 		$775K Sell
10,360
-100
-1% -$7.62K 0.12% 114
2021
Q2 		$809K Sell
10,460
-200
-2% -$14.9K 0.12% 111
2021
Q1 		$787K Sell
10,660
-1,315
-11% -$99.5K 0.13% 108
2020
Q4 		$840K Sell
11,975
-741
-6% -$46.9K 0.15% 104
2020
Q3 		$720K Sell
12,716
-3,396
-21% -$200K 0.14% 103
2020
Q2 		$939K Sell
16,112
-202
-1% -$11K 0.2% 89
2020
Q1 		$758K Sell
16,314
-575
-3% -$30K 0.22% 74
2019
Q4 		$943K Sell
16,889
-725
-4% -$37.8K 0.22% 77
2019
Q3 		$835K Sell
17,614
-562
-3% -$28.8K 0.21% 80
2019
Q2 		$973K Sell
18,176
-815
-4% -$42.3K 0.25% 79
2019
Q1 		$1.05M Sell
18,991
-1,345
-7% -$71.1K 0.28% 75
2018
Q4 		$958K Sell
20,336
-125
-0.6% -$6.42K 0.3% 71
2018
Q3 		$1.22M Sell
20,461
-154
-0.7% -$8.99K 0.33% 70
2018
Q2 		$1.13M Sell
20,615
-710
-3% -$36.1K 0.33% 67
2018
Q1 		$1.05M Sell
21,325
-2,717
-11% -$139K 0.32% 68
2017
Q4 		$1.13M Sell
24,042
-569
-2% -$26.7K 0.33% 64
2017
Q3 		$1.23M Sell
24,611
-50
-0.2% -$2.37K 0.39% 60
2017
Q2 		$1.13M Sell
24,661
-785
-3% -$33.9K 0.36% 62
2017
Q1 		$1.08M Sell
25,446
-625
-2% -$26.2K 0.37% 63
2016
Q4 		$1.01M Sell
26,071
-2,240
-8% -$90.4K 0.36% 63
2016
Q3 		$1.19M Sell
28,311
-10,120
-26% -$416K 0.43% 56
2016
Q2 		$1.42M Sell
38,431
-1,459
-4% -$57.2K 0.52% 51
2016
Q1 		$1.53M Sell
39,890
-9,697
-20% -$377K 0.56% 50
2015
Q4 		$2.5M Sell
49,587
-5,771
-10% -$285K 0.95% 32
2015
Q3 		$2.53M Sell
55,358
-1,335
-2% -$74.6K 1% 31
2015
Q2 		$3.31M Buy
56,693
+415
+0.7% +$23.7K 1.22% 24
2015
Q1 		$3.1M Buy
56,278
+2,646
+5% +$143K 1.16% 27
2014
Q4 		$2.69M Sell
53,632
-530
-1% -$25.9K 1.06% 30
2014
Q3 		$2.5M Buy
54,162
+1,790
+3% +$80.6K 1.02% 30
2014
Q2 		$2.29M Buy
52,372
+19,793
+61% +$802K 0.96% 33
2014
Q1 		$1.36M Sell
32,579
-1,175
-3% -$50.3K 0.58% 46
2013
Q4 		$1.25M Sell
33,754
-460
-1% -$16.5K 0.55% 46
2013
Q3 		$1.2M Buy
34,214
+25
+0.1% +$828 0.58% 46
2013
Q2 		$987K Buy
+34,189
New +$972K 0.51% 46

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Hills Bank & Trust's PBE Position: Q1 2026 in Review

Hills Bank & Trust held its Invesco Biotechnology & Genome ETF (PBE) position steady in Q1 2026 at 4,559 shares worth $361K. The position accounts for 0.02% of the portfolio, ranked #235.

Hills Bank & Trust first reported a position in PBE in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.31M in Q2 2015. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.

  • Hills Bank & Trust held 4,559 shares of Invesco Biotechnology & Genome ETF worth $361K as of Q1 2026.
  • Hills Bank & Trust left its Invesco Biotechnology & Genome ETF share count unchanged in Q1 2026.
  • Invesco Biotechnology & Genome ETF made up 0.02% of Hills Bank & Trust's portfolio in Q1 2026, its #235 holding.
  • Hills Bank & Trust first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and has held it in 52 quarters since.
  • Hills Bank & Trust's Invesco Biotechnology & Genome ETF position peaked at $3.31M in Q2 2015.
  • 100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.

Based on Hills Bank & Trust's 13F filing for Q1 2026, filed 1 May 2026.